# ZANVASTRO
> **NDA220210** · New Drug Application · Sponsor: IONIS PHARMS INC · Approved 2026-09-03
## Drug
- **FDA Application Number:** NDA220210
- **Application type:** New Drug Application
- **Brand name:** ZANVASTRO
- **Generic name:** Zilganersen Sodium
- **Active ingredients:** ZILGANERSEN SODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRATHECAL
- **Marketing status:** Prescription
- **Sponsor:** IONIS PHARMS INC
- **First approval:** 2026-09-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220210)
---
*MORVS · CC0 1.0*